Eclipse Diagnostics
Early Stage
Preventing Stroke At Home
Overview
Raised: $171,750
Rolling Commitments ($USD)
Status
Funded
Reporting Date
11/04/2018
Days Remaining
Funded
% of Min. Goal
1,718%
% of Max. Goal
16%
Likelihood of Max
Funded
Avg. Daily Raise
$719
# of Investors
94
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2018
Industry
Farming & Agriculture
Tech Sector
AgriTech
Location
Los Angeles, California
Who Should Be Interested:
Are you a stroke survivor, or a diabetic patient? Do you know someone who has experienced the scariness of a stroke? If you are, or if you have, then investing in Eclipse Diagnostics could be the move for you. They’re developing an innovative new technology that will help prevent strokes at home.
The Company:
Eclipse Diagnostics wants to truly help eclipse the surprise of strokes. They’re developing an easy-to-use home device to monitor the risk of stroke -- and hopefully prevent it. There is a blood marker that, when elevated, indicates a high risk of stroke. By monitoring this blood marker at least once a week, patients will be able to see early warning signs and visit a doctor for further diagnostics. Eclipse’s patented technology and device is easy to use. Users simply prick their finger for a drop of blood, put it into the disposable one-time-use test strip, and a bluetooth device reads the strip. The device connects to a smartphone app that gathers and processes the information, and if the user’s biomarkers reach dangerous levels, the app will provide a warning and alert. This is the first device of its kind to allow patients to monitor their stroke risk at home -- and take preventable action as a result.
The Bottom Line:
Stroke is currently the fifth leading cause of death in the US -- but up to 80% of strokes can be prevented. Eclipse Diagnostics is giving diabetics and at-risk patients the chance to monitor early warning signs, reach out to a doctor when needed...and ultimately prevent the stroke from happening at all.
Are you a stroke survivor, or a diabetic patient? Do you know someone who has experienced the scariness of a stroke? If you are, or if you have, then investing in Eclipse Diagnostics could be the move for you. They’re developing an innovative new technology that will help prevent strokes at home.
The Company:
Eclipse Diagnostics wants to truly help eclipse the surprise of strokes. They’re developing an easy-to-use home device to monitor the risk of stroke -- and hopefully prevent it. There is a blood marker that, when elevated, indicates a high risk of stroke. By monitoring this blood marker at least once a week, patients will be able to see early warning signs and visit a doctor for further diagnostics. Eclipse’s patented technology and device is easy to use. Users simply prick their finger for a drop of blood, put it into the disposable one-time-use test strip, and a bluetooth device reads the strip. The device connects to a smartphone app that gathers and processes the information, and if the user’s biomarkers reach dangerous levels, the app will provide a warning and alert. This is the first device of its kind to allow patients to monitor their stroke risk at home -- and take preventable action as a result.
The Bottom Line:
Stroke is currently the fifth leading cause of death in the US -- but up to 80% of strokes can be prevented. Eclipse Diagnostics is giving diabetics and at-risk patients the chance to monitor early warning signs, reach out to a doctor when needed...and ultimately prevent the stroke from happening at all.
Create a free account today to gain access to KingsCrowd analytics.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Are you the founder of Eclipse Diagnostics? Create your account today to claim this raise page.